Samuel C. Blackman sold $427K of Day One Biopharmaceuticals (DAWN)

Executed Sep 10 2024, disclosed Sep 12 2024, 2 days later.

Value, as filed

$427K

30,000 sh × $14.22

Executed

Sep 10 2024

the trade date, as filed

Disclosed

Sep 12 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SB Samuel C. Blackman HEAD OF R&D profile →

Samuel C. Blackman (HEAD OF R&D) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in DAWN. The largest single filing was $456K of DAWN (28,255 sh across 2 lots, as filed), executed Nov 8 2024.

The name

DAWN DAWN DAWN · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Samuel C. Blackman in DAWN

DAWNSALE Day One Biopharmaceuticals, Inc. $399K
30,000 sh × $13.31
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET DAWNSALE Day One Biopharmaceuticals, Inc. $456K
28,255 sh across 2 lots
Exec Nov 8 2024
Filed Nov 12 2024 · 5:30 PM ET DAWNSALE Day One Biopharmaceuticals, Inc. $180K
11,245 sh × $16.03
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET